|
J Biol Chem, Vol. 273, Issue 39, 25089-25097, September 25, 1998
Potential Regulation of Ste20 Function by the Cln1-Cdc28 and
Cln2-Cdc28 Cyclin-dependent Protein Kinases*
Lambertus J. W. M.
Oehlen and
Frederick R.
Cross
From the Rockefeller University, New York, New York 10021
 |
ABSTRACT |
The activity of the Saccharomyces
cerevisiae pheromone signal transduction pathway is regulated by
Cln1/2-Cdc28 cyclin-dependent kinase. High level expression
of CLN2 can repress activation of the pathway by mating
factor or by deletion of the -subunit of the heterotrimeric
G-protein. We now show that CLN2 overexpression can also
repress FUS1 induction if the signaling pathway is
activated at the level of the -subunit of the G-protein
(STE4) but not when activated at the level of downstream
kinases (STE20 and STE11) or at the level of
the transcription factor STE12. This epistatic analysis
indicates that repression of pheromone signaling pathway by Cln2-Cdc28
kinase takes place at a level around STE20. In agreement with this, a marked reduction in the electrophoretic mobility of the
Ste20 protein is observed at the time in the cell cycle of maximal
expression of CLN2. This mobility change is constitutive in
cells overexpressing CLN2 and absent in cells lacking
CLN1 and CLN2. These changes in electrophoretic
mobility correlate with repression of pheromone signaling and suggest
Ste20 as a target for repression of signaling by G1
cyclins. Two morphogenic pathways for which Ste20 is essential,
pseudohyphal differentiation and haploid-invasive growth, also require
CLN1 and CLN2. Together with the previous
observation that Cln1 and Cln2 are required for the function of Ste20
in cytokinesis, this suggests that Cln1 and Cln2 regulate the
biological activity of Ste20 by promoting morphogenic functions, while
inhibiting the mating factor signal transduction function.
 |
INTRODUCTION |
Binding of mating factor to a specific receptor in haploid
Saccharomyces cerevisiae cells activates a signal
transduction pathway that prepares for conjugation with cells of the
opposite mating type. The transduction of the signal starts with
binding of the peptide mating factor to a seven-transmembrane domain
receptor (Ste2 in a mating type cells and Ste3 in
-cells), which then activates a heterotrimeric G-protein by
releasing an active - complex from the inhibitory -subunit
( -, -, and -subunits are encoded, respectively, by the
GPA1, STE4, and STE18 genes). The
activated G-protein transmits the signal to a set of serine/threonine protein kinases that are activated in a sequential order. The first of
these is Ste20, a member of the family of p21-activated kinases
(PAKs),1 and then Ste11 (a
MAP kinase kinase kinase), Ste7 (a MAP kinase kinase), and finally a
MAP kinase (Fus3 or in some cases Kss1) are activated. Activation of
the MAP kinase (i) stimulates the transcription of many genes involved
in the conjugation process through the transcription factor Ste12, (ii)
results in arrest in G1-phase of the cell cycle through the
Far1 protein, and (iii) leads to specific morphological changes that
are required for efficient cell fusion. Several review articles (1-4)
describe the mating factor signal transduction pathway and other MAP
kinase-based pathways in more detail.
Some of the components of the mating factor signal transduction pathway
are required for functions other than sexual differentiation. Agar-invasive growth of haploid cells (haploid-invasive growth) and
pseudohyphal growth of diploid cells both require Ste20, Ste11, Ste7,
and Ste12 (5-7). In addition, from the lethal phenotype of cells that
are deleted for both Ste20 and Cla4, a related PAK family member,
Ste20, appears to share a function in the budding/cytokinesis cycle
with Cla4 (8). The overlap in function is only partial, as Cla4 has no
known function in mating factor signal transduction. Therefore, Ste20
is not only critical for sexual differentiation in response to mating
factor but can also play a role in morphogenesis during the vegetative
cell cycle. The small G-protein Cdc42 can interact with a specific
domain in the N terminus of Ste20 that is conserved among PAK family
members (2). This interaction of Cdc42 with Ste20 is dispensable for
in vitro kinase activity and the mating factor signal
transduction functions of Ste20 but appears critical for the vegetative
morphological roles of Ste20 (9-11). Similarly, full morphogenic
function of Cla4 also requires interaction of Cla4 with Cdc42 (12).
Both the basal activity (in absence of ligand stimulation) and the
mating factor-induced activity of the mating factor signal transduction
pathway are cell cycle-regulated (13-15). In the absence of mating
factor stimulation, fluctuations are observed for transcripts of many
genes that are involved in the mating reaction and whose transcription
involves Ste12 (13-16). A common pattern for transcription of such
genes is that transcription is high in G1-phase and then declines as cells enter S-phase (15). The activity of the Fus3 protein
kinase shows a similar cell cycle pattern (17), and this regulation is
likely to be required for the cell cycle regulation of basal
transcription. The mating factor-induced signal transduction activity
is also strictly regulated, with maximal activation during M/G1-phase, and reduced activation in S-phase (13, 14).
This regulation of the induced signal transduction activity depends specifically on the G1 cyclins CLN1 and
CLN2 (14). These cyclins are expressed in late
G1-phase, and when Cln1 and Cln2 associate with the
cyclin-dependent kinase (CDK) Cdc28, they help to promote the transition of cells from G1- to S-phase (18, 19). High level expression of CLN2 strongly reduces induction of
mating specific genes by mating factor or by deletion of the
-subunit of the heterotrimeric G-protein (14). This suggest that
regulation of mating factor signal transduction activity by
Cln1/2-Cdc28 takes place at a level downstream of the mating factor
receptor and the -subunit.
Here we present a more detailed analysis of the regulation of the
mating factor signal transduction pathway by the G1 cyclins CLN1 and CLN2. A combination of genetic,
biochemical, and cell biological observations suggests that
Cln1/2-Cdc28 regulate the function of the Ste20 protein kinase.
 |
MATERIALS AND METHODS |
Yeast Strains and Plasmids--
The genotypes of the strains
used in this study are given in Table I.
Strains were isogenic to BF264-15D (trp1-1a leu2-3, 112 ura3 ade1
his2) except where indicated. Strains were constructed by standard
techniques for crossing and gene replacement (20). Plasmids that
provided fragments for the creation of disruption alleles are as
follows: pAB506 (ste2::LEU2 (21)), pM59p7
(ste18::URA3 (22)), p4-121
(ste4::LEU2 (provided by V. MacKay, Seattle)), pSF32 (ste5::URA3 (provided by V. MacKay,
Seattle)), pEL45 (ste20::URA3 (23)), pSL1094
(ste11::URA3 (24)), pNC113
(ste7::LEU2 (25)), pBC65
(kss1::URA3 (26)), pYEE98
(fus3::LEU2 (27)), pSUL16 (ste12::LEU2 (28)), pBB119
(cla4::TRP1 (12)), pPB590
(akr1::URA3 (29), pKO2 (= pPB642,
bem1::LEU2 (30)). Gene disruptions were made by
one-step gene replacement with appropriately digested DNA. In some
cases the original auxotrophic markers on disruption cassettes were
altered using "marker swap" plasmids (31). Deletion alleles for
CLN genes and CLN expression constructs were as
described previously (14). Other plasmids used were as follows: pL19
(pURA3-GAL1::STE4 (32)),
pURA3-GAL1::STE20 N (33), pVTU-STE20
(pURA3-ADH-STE20 (23)), pGA2013
(pTRP1-GAL1::STE5-myc (provided by G. Ammerer, Vienna)), pGU-STE11 N (pURA3-
GAL1::STE11 N (34)), pSL1508 and pSL1509 (respectively
pURA3-STE11.1 and pURA3-STE11.4 (24)), and pGK40
(pURA3-GAL1::STE12 (35)).
Growth Conditions and Synchronization Procedures--
Cells were
grown in YEP medium or synthetic dropout medium with raffinose,
galactose, or dextrose as described (14). Assays for pseudohyphal
growth in diploid cells and agar-invasive growth in haploid cells were
performed as described (5, 7). Cell cycle synchronization of
cln1 , cln2 , and cln3
cells by conditional cyclin expression from the
GAL1 promoter and synchronization protocols for strains with
thermosensitive cdc15-2 and cdc28-13 alleles were
as described (14). Cell cycle progression was followed by determining
the fraction of unbudded cells or by analysis of transcripts with known
patterns of cell cycle regulation.
RNA Hybridization and Immunoblot Analysis--
Procedures for
RNA hybridization ("Northern") mRNA analysis were as described
previously (16). FUS1 and CLN2 DNA restriction fragments were excised from low melting point agarose gels, and SST2, TCM1, and H2A fragments were generated by
polymerase chain reaction as described (15). DNA fragments were
radiolabeled by random-prime labeling using a Prime-It kit
(Stratagene), and transcript levels were visualized and quantitated
using a Molecular Dynamics STORM PhosphorImager system. Immunoblot
("Western") protein analysis by enhanced chemiluminescence was
essentially as described (15). Polyclonal rabbit antibodies, which were
raised against residues in kinase-domains VI or XI of Ste20
(Kinetek, Richmond, British Columbia, Canada), were used at a
dilution 1:2000.
 |
RESULTS |
Repression of Pheromone Signal Transduction Takes Place Around the
Level of Ste20--
We have previously shown that constitutive
expression of CLN2 from the strong GAL1 promoter
can effectively block the response to mating factor (14). Activation of
the mating factor pathway by deletion of the -subunit of the
heterotrimeric G-protein can also be repressed by overexpression of
CLN2 (14). This latter observation suggests that inhibition
of the mating factor pathway by CLN2 takes place at a level
downstream of the mating factor receptor and the -subunit of the
G-protein. We wanted to determine the site of action of Cln2 on the
mating factor pathway more precisely. For this epistatic analysis, we
used expression constructs of particular genes, whose high level
expression has been shown to induce the mating factor response pathway.
Among these are STE4 (the -subunit of the G-protein)
(32), activated alleles of the STE20 and STE11
kinases (24, 33, 34), the "scaffolding" protein STE5
(36, 37), and the transcription factor STE12 (35). We
studied the effect of simultaneous expression of CLN2 and
these activators of the mating factor response pathway (Fig. 1). In all cases the signal transduction
activity of wild type cells and GAL1::CLN2 cells
without the expression construct served as a control. As shown in Fig.
1A, overexpression of CLN2 from the
GAL1 promoter can prevent the induction of FUS1
transcription caused by overexpression of STE4. Even when
STE4-overexpressing cells were treated with mating factor,
simultaneous overexpression of CLN2 could prevent the
induction of FUS1. In contrast, overexpression of a
truncated allele of STE20 (STE20 N, Fig.
1B), a truncated allele of STE11
(STE11 N, Fig. 1D) and STE12 (Fig.
1E), resulted in elevated levels of FUS1
transcription in the presence of high levels of CLN2. In all
these cases, expression of CLN2 from the GAL1
promoter also failed to prevent the additional elevation of
FUS1 transcript levels by addition of mating factor (Fig. 1, B, D, and E). (It should be noted
that, in a previous publication (14), we have referred to preliminary
results that appeared to show epistasis of
GAL1::STE4 to GAL1::CLN2.
These data now turn out to be incorrect and were probably due to a
mix-up of plasmids. We wish to apologize for any problem that this may
have caused.).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Epistatic analysis of repression of mating
factor signal transduction by high level expression of CLN2. Cells
were grown to early exponential phase in synthetic dropout medium with
raffinose as a carbon source. Then galactose was added to all cultures
for several hours to induce the various constructs driven from the
GAL1 promoter. Samples were taken for Northern analysis
before and after 15 min mating factor stimulation. Blots were probed
for FUS1 transcript to monitor activity of the signal
transduction pathway and for TCM1 transcript to control for
loading in all lanes. Transcript levels were quantitated using a STORM
PhosphorImager system, and the data shown are FUS1 levels
corrected for loading. Samples before mating factor stimulation are
shown by gray bars and mating factor-stimulated samples by
black bars. For each panel, the mating factor-induced
FUS1level in wild-type cells was arbitrarily chosen as 100 units, and
other transcript levels in that panel are given in relation to this
value. A, strains 1255-5C (wt) or BOY1037
(GAL1::CLN2) were transformed with pL19
(pURA3-GAL1::STE4) or vector controls. Induction
in galactose was for 3 h. B, same strains as in
A transformed with
pURA3-GAL1::STE20 N or vector controls.
Induction in galactose was for 14 h. C, same strains as
in A transformed with pGA2013
(pTRP1-GAL1::STE5) or vector controls. Induction
in galactose was for 5 h. D, strains BOY391
(wt) or BOY389 (GAL1::CLN2) were
transformed with pGU-STE11 N
(pURA3-GAL1::STE11 N) or vector controls.
Induction in galactose was for 5 h. E, same strains as
in D were transformed with pGK40
(pURA3-GAL1::STE12) or vector controls. Induction
in galactose was for 5 h.
|
|
We found that high level CLN2 expression not only failed to
down-regulate elevated FUS1 transcription induced by
GAL1::STE11 N (Fig. 1D) but also
SST2 transcription (the transcript is regulated similarly to
FUS1 (38)) induced by activated STE11 alleles
(STE11-1 and STE11-4 (24)) expressed from their
own promoter (Fig. 2D). In
fact, high level CLN2 expression may somewhat enhance the
effect of the STE11-4 allele on SST2
transcription. This finding is in contrast to results that were
recently reported by others (17). Even using the same strains that were
used in that study (17), we have been unable to reproduce the result
that high level CLN2 expression represses the elevation of
FUS1 transcription caused by the activated alleles
STE11-1 and STE11-4 (data not shown). The results
shown in Fig. 2D cannot be explained by ineffective expression of CLN2, as mating factor-induced transcription
of SST2 is effectively blocked by high level CLN2
expression in these cells (Fig. 2E). We have no explanation
at present for this discrepancy.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 2.
Epistatic analysis of the site of action of
STE20, STE5, and STE11. FUS1 (A and
B) or SST2 (C and D)
transcript levels were determined by Northern analysis. Quantitation
and correction for loading were as in Fig. 1. A, wild type
cells or cells deleted for one of the components of the mating factor
signal transduction pathway were transformed with plasmid
pURA3-GAL1::STE20 N or vector controls. Cells
were grown to early exponential phase in raffinose medium, and then
STE20 expression was turned on for 14 h by addition of
galactose. Transcript levels in wild type cells with
pURA3-GAL1::STE20 N were arbitrarily chosen as
100 units. Strains used were as follows: 1255-5C (wild type), BOY575
(ste2::LEU2), BOY1151
(ste18::LEU2), BOY527
(ste4::LEU2), BOY1149
(ste5::LEU2), BOY1289
(ste11::TRP1), BOY763
(ste7::LEU2), BOY906 (fus3::TRP1
kss1::LEU2), BOY529 (ste12::LEU2).
B, wild type cells or cells deleted for one of the
components of the mating factor signal transduction pathway were
transformed with pGA2013 (pTRP1-GAL1::STE5) or
vector controls. Cells were grown to early exponential phase in
raffinose medium, and STE5 expression was turned on for
6 h by addition of galactose. Transcript levels in wild type cells
with pTRP1-GAL1::STE5 were arbitrarily chosen as
100 units. Strains used were as follows: BOY594
(ste20::URA3), BOY1277
(ste11::URA3), BOY522 (fus3::URA3
kss1::LEU2) and other strains as in A.
C, wild type (BOY443) and ste20 (BOY445) cells
with pSL1508 (pURA3-STE11-1), pSL1509
(pURA3-STE11-4), or vector controls were grown to
exponential phase in selective dextrose medium. Transcript levels in
wild type cells with vector were arbitrarily chosen as 100 units.
D, wild type (BOY443) and GAL1::CLN2
(BOY1427) cells with pSL1508 (pURA3-STE11-1), pSL1509
(pURA3-STE11-4), or vector controls were grown to
exponential phase in selective galactose medium. Treatment of selected
samples with mating factor was for 15 min at 0.1 µM final
concentration. Transcript levels in wild type cells with vector were
arbitrarily chosen as 100 units. E, wild type (BOY443) and
GAL1::CLN2 (BOY1427) cells transformed with empty
vector were grown to exponential phase in selective galactose medium.
Treatment with mating factor was for 15 min at 0.1 µM
final concentration. Transcript levels in wild type cells with vector
were arbitrarily chosen as 100 units.
|
|
The GAL1::STE20 N construct fails to complement
the mating defect of ste4, ste5,
ste11, ste7, and ste12 cells (33). To
provide additional epistatic information, we determined the effects of overexpression of GAL1::STE20 N on
FUS1 transcription in strains that were deleted for various
components of the mating factor signal transduction pathway (Fig.
2A). Induction of FUS1 by
GAL1::STE20 N was observed in cells lacking the
mating factor receptor (STE2), components of the
heterotrimeric G-protein (STE4 and STE18), and STE5. However, other components of the signal transduction
pathway were required for GAL1::STE20 N-induced
FUS1 transcription. These data are consistent with the
established epistatic position of STE20 downstream of the
G-protein and upstream of the STE11-STE7-MAP kinase cassette
(23) and thus demonstrate the usefulness of the
GAL1::STE20 N construct for epistatic
analysis.
The epistatic position of STE5 in the mating factor response
pathway is complicated, possibly because of the many proteins with
which Ste5 interacts (39). A GAL1::STE5 construct
has been used previously in epistatic experiments, but when plating
efficiency of cells containing a GAL1::STE5
plasmid was monitored, this yielded rather complex results (36). We
tested the FUS1 induction by the
GAL1::STE5 construct in strains deleted for
various components of the signal transduction pathway (Fig.
2B). FUS1 induction by overexpression of
STE5 required, with the exception of STE2, the presence of all the tested components of the mating factor signal transduction pathway. Activated alleles of STE5 were
previously shown to partially complement the mating defect of strains
deleted for the mating factor receptor, components of the
heterotrimeric G-protein or Ste20, but not deletion of components of
the STE11-STE7-MAP kinase cassette (23, 37). Our data
confirm the findings of Hasson et al. (37) and extend
previous analyses (37, 40) by showing that induction of FUS1
by high level expression of STE5 also requires
STE20. The failure of induction of FUS1 by GAL1::STE5 in ste20 cells suggests
that slow growth of such cells that was observed by Akada et
al. (36) is not due to increased transcriptional activity of the
mating factor response pathway. On the whole, the data obtained with
GAL1::STE5 constructs yield rather complex results
that are difficult to place in an epistatic series and therefore are of
limited use in establishing the position of the negative effect of
Cln2-Cdc28 on the mating factor signal transduction pathway. Because of
this, the observation that GAL1::CLN2 expression
represses the signal generated by GAL1::STE5 only
in the absence, and not in the presence of mating factor (Fig.
1C), is also difficult to interpret.
The epistatic position of Ste11 in relation to most other components of
the mating factor signal transduction pathway is fairly well
established by transcriptional-induction and mating-complementation assays using STE11-1 and STE11-4 alleles (24) or
the GAL1::STE11 N construct (34). The
observation that STE11-1 and STE11-4 also induce
significant levels of SST2 in ste20 cells (Fig.
2C) is consistent with the general notion that Ste11 acts
downstream of Ste20.
Taken together, the data presented in Figs. 1 and 2 show that
GAL1::CLN2 represses the mating factor pathway at
a level which is at or downstream of STE4 and at or upstream
of STE20. The observations that mating factor-induced
hyperphosphorylation of Ste7 (41), tyrosine phosphorylation of Fus3
(42) (assayed with anti-phosphotyrosine antibodies in
immunoprecipitates of Fus3), and Fus3 kinase activation can be
prevented by high level expression of CLN2 (data not shown (15)) are consistent with this epistatic placement of the negative effect of Cln2-Cdc28 on the mating factor response pathway. Since the
Ste20 protein is one of the potential targets suggested by epistatic
analysis and since studies of the Ste20 homolog Cla4 suggest a
potential genetic interaction between Ste20 and the G1
cyclins CLN1 and CLN2 (8, 12), we focused on
Ste20 as a potential site for repression of mating factor signal
transduction.
The Electrophoretic Mobility of Ste20 Changes during the Cell
Cycle--
We first looked at the abundance of the Ste20 protein at
various cell cycle stages. For this purpose, temperature-sensitive cdc15-2 cells were arrested in late M-phase at restrictive
temperature, and synchronous cell cycle progression was then initiated
by lowering the temperature. Ste20 appears to be present at all cell
cycle positions, but there are marked changes in the mobility of the protein when cells progress through the cell cycle (Fig.
3). The mobility of the protein on
SDS-PAGE gels was relatively fast in late M- and early
G1-phase, but Ste20 in late G1 cells and
S-phase migrated markedly slower (Fig. 3). This "upshift" in
mobility of Ste20 followed peak levels of CLN2 transcription
and roughly coincided with the previously identified period of
repression of the mating factor pathway by Cln1/2-Cdc28 (Fig. 3 (14)). Similar observations were made on the native STE20 driven
from its own promoter, showing that the continued presence of Ste20 through the cell cycle is not some artifact of overexpression of the
protein (data not shown). Since Ste20 protein levels of the
STE20 gene expressed from its own promoter were markedly
lower than if STE20 is expressed from either the
ADH promoter or the GAL1 promoter (data not
shown), further analysis of the Ste20 protein was performed using these
ectopic expression constructs.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 3.
Ste20 mobility changes through the cell
cycle. Temperature-sensitive cdc15-2 (BOY501) cells
with plasmid VTU-STE20 (pURA3-ADH-STE20) were grown to early
exponential phase at 23 °C and then arrested in late M-phase by
incubation at 36 °C for 3 h. Synchronous cell cycle progression
was initiated by lowering the temperature back to 23 °C. Samples
were taken every 15 min for Northern and Western analysis.
CLN2 and H2A transcript levels serve as cell
cycle position indicators for late G1- and S-phase,
respectively, and TCM1 transcripts were used as a loading
control for all lanes. The upper panel shows Ste20 protein
levels as determined in total denaturing extracts upon SDS-PAGE on 6%
gels.
|
|
Changes in the Mobility of Ste20 Are
Cln1/2-dependent--
Combining the data from the
epistatic analysis (Fig. 1) with the data on the cell cycle-regulated
mating factor signal transduction (14) and cell cycle-regulated
mobility changes of Ste20 (Fig. 3), we wanted to test whether the
change in mobility of Ste20 was important for repression of the mating
factor pathway by Cln1/2-Cdc28 kinase. If the upshift in mobility was
important for repression, it could be expected that the upshift, like
repression, is (i) dependent on the presence of CLN1/2 and
(ii) constitutive in cells that overexpress CLN2. To test
this potential connection, we first followed the mobility of Ste20 in
cln1 cln2 CLN3 cells compared with cells that did contain
the CLN1 and CLN2 cyclins. The same strains and
synchronization protocols were used for this analysis that were used
previously to show that repression of the mating factor response
pathway depends on the presence of CLN1 and CLN2 (14). Also with this different method of synchronization, the CLN wild type cells showed a change in the mobility of Ste20
at about the time when CLN1/2 are normally maximally
expressed and cells enter S-phase (Fig.
4A). The cell cycle pattern of
the electrophoretic mobility changes of Ste20 in CLN1 CLN2
cln3 cells was very similar to that in wild type cells (data not
shown). In contrast, the upshift in mobility of Ste20 was not observed
in cells lacking CLN1 and CLN2 (Fig.
4B). The absence of an upshift of Ste20 in cln1 cln2
CLN3 cells correlates with the previously shown absence of
repression of the mating factor signal transduction in these cells
(14).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 4.
Changes in Ste20 mobility depend on
CLN1/2. Temperature-sensitive cdc28-13 cells with
plasmid VTU-STE20 (pURA3-ADH-STE20) were grown to early
exponential phase at 30 °C and then arrested at START by incubation
at 37 °C for 3 h. Synchronous cell cycle progression was
initiated by lowering the temperature back to 30 °C. Samples were
taken every 15 min for Western analysis and morphological examination.
The percentage on unbudded cells in each sample was determined by
scoring 200 cells. Ste20 protein levels were determined in total
denaturing extracts upon SDS-PAGE on 6% gels. A, samples
taken from cdc28-13 cells with wild type CLN
genotype (strain BOY743). B, samples from cln1 cln2
4×CLN3 cdc28-13 cells (strain BOY1143).
|
|
To test the second prediction that overexpression of CLN2
might strongly affect the mobility of Ste20, we monitored the mobility of Ste20 in cln cells that were synchronized by
conditional expression of either CLN1, CLN2, or
CLN3 from the GAL1 promoter. These cells were
grown on galactose medium and then shifted to raffinose, which results
in a quantitative arrest at START due to G1 cyclin deprivation. Re-addition of galactose to these cultures then started synchronous cell cycle progression. We previously showed that repression of the mating factor pathway is strong in cells with GAL1::CLN2 and is absent in
GAL1::CLN3 cells (14). It was found that the
upshift in Ste20 mobility as cells enter S-phase was only observed in
GAL1::CLN1 and GAL1::CLN2
cells (Fig. 5, A and B) but not in GAL1::CLN3 cells (Fig.
5C). After turning on the GAL1 promoter, the
upshift in the GAL1::CLN2 cells was almost quantitative at all cell cycle positions (Fig. 5B). This
strong alteration of electrophoretic mobility of Ste20 therefore
correlates well with the strong negative effect of this CLN2
construct on the pheromone signaling pathway (14) (Fig. 1). There are
various indications that Cln1 and Cln2 have distinct biological
activities from Cln3 (e.g. Ref. 43). It has been shown that
epitope-tagged versions of CLN3 expressed at high level,
from high copy number plasmids or from the GAL1 promoter,
have at least equal in vitro H1 kinase activity as
CLN2 expressed from its own promoter (43). Also,
CLN3 expressed from either its own or from the
GAL1 promoter provides sufficient biological activity
in vivo to efficiently promote START. The absence of an
alteration in Ste20 mobility in the GAL1::
CLN3-synchronized cells is therefore unlikely due to a general
reduction in START-promoting Cln-Cdc28 kinase activity but is much more
likely to be another example where Cln1 and Cln2 differ in their
biological activities from Cln3. Treatment of purified fast and slow
migrating forms of Ste20 with phosphatase shows that the
Cln1/2-Cdc28-mediated changes in electrophoretic mobility are probably
mostly due to phosphorylation (data not shown).2

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 5.
Ste20 mobility in GAL1::CLN
synchronized cells. cln cells, containing plasmid VTU-STE20
(pURA3-ADH-STE20), with CLN1, CLN2, or
CLN3 expressed from the GAL1 promoter were grown
to early exponential phase in galactose and then arrested at START by
shift to raffinose medium for 2.5 h. Synchronous cell cycle
progression was initiated by addition of galactose. Samples were taken
every 12 min for Western analysis and morphological examination. The
percentage on unbudded cells in each sample was determined by scoring
200 cells. Ste20 protein levels were determined in total denaturing
extracts upon SDS-PAGE on 6% gels. A, samples taken from
synchronized cln GAL1::CLN1 cells (strain
BOY836). B, samples taken from synchronized cln
GAL1::CLN2 cells (strain BOY183). C, samples
taken from synchronized cln GAL1::CLN3 cells
(strain BOY747).
|
|
Taken together these data show a strong correlation between retardation
of Ste20 mobility in SDS-PAGE gels and repression of the mating factor
response pathway as follows: both the upshift and repression (i) occur
at about the time of maximal activity of the Cln1/2-Cdc28 kinase, (ii)
depend on CLN1/2, and (iii) are constitutive in cells
expressing CLN2 from the GAL1 promoter.
One specific model that could explain the tight correlation between
upshift and repression is that Cln1/2-Cdc28 inactivates Ste20 kinase.
However, no effect was observed of CLN overexpression or
CLN1/2 deletion on overall in vitro Ste20 kinase
activity (9).2 Since there did not seem to be an alteration
in the chemical activity of the Ste20 kinase, we considered the
possibility that CLN1/2 affects the biological activity of
Ste20 and that the fast migrating and slower migrating forms of Ste20
represent species of Ste20 with distinct biological activities.
Genetic Interactions Suggest Bem1 and Akr1 as Components of a
Pathway for Ste20-dependent Regulation of
Cytokinesis--
Cells lacking either Ste20 or Cla4 are viable,
whereas cells lacking both STE20 and CLA4 are
inviable (8). Based on the morphology of ste20 cla4 cells,
it was suggested that these two PAK family members share an essential
morphogenic function at cytokinesis (8). Interestingly, cln1 cln2
cla4 cells are also inviable, with an arrest
phenotype that resembles that of ste20 cla4
cells (8, 12). This suggests that Cln1/2 and Ste20 function in a
similar pathway and that maybe the modification of Ste20 by Cln1/2 is
required for its cytokinesis function. The mechanism by which Ste20 and
Cla4 promote cytokinesis is unknown, but since ste11 cla4
and ste5 cla4 cells are viable, an intact mating factor or
haploid-invasive signal transduction route is not essential (8). In an
attempt to identify potential factors that are required for the
cytokinesis function of Ste20, we tested the synthetic phenotype of
CLA4 deletion in combination with deletion of other proteins
that are known to interact directly or indirectly with Ste20. In both
genetic and biochemical assays, Ste4 has been shown to interact with
Ste20 (4, 45). Tetrad analysis revealed that ste4::LEU2
cla4::TRP1 cells were viable
(Table II, entry A), which is consistent
with the notion that an intact mating factor signal transduction
pathway is not required for the essential morphogenic role of Ste20.
Ste4 has been shown to physically interact with Akr1, a protein with a
role in mating factor signal transduction and cell morphogenesis (29,
46). Tetrad analysis of spores from a cross of MATa
akr1::URA3 to MATalpha cla4::TRP1
cells revealed that cla4::TRP1
akr1::URA3 cells were inviable (Table II, entry B). The
Akr1 requirement for viability is specific to cla4 cells, since ste20 akr1 cells are fully viable (46)
(Table II, entry C). This suggests that Akr1 is required for the
essential vegetative morphogenic role of Ste20 in the absence of Cla4.
Ste20 has also been shown to be part of a complex of proteins that
includes actin, Bem1, and Ste5 (47). Since Bem1 is important for proper
morphogenesis in response to mating factor (29, 48, 49), we tested
whether it could also be important for the vegetative morphogenic role of Ste20. We crossed MATa bem1::LEU2 to
MATalpha cla4::TRP1 cells and found no viable
cla4::TRP1 bem1::LEU2 double mutants
upon sporulation and tetrad analysis (Table II, entry D). This
synthetic lethality of cla4 and bem1 is
consistent with the idea that the interaction between Bem1 and Ste20 is
important for the vegetative morphogenic role of Ste20.
View this table:
[in this window]
[in a new window]
|
Table II
Genetic interaction of Cla4 with Akr1 and Bem1
Only tetrads with three or four spores were analyzed. The genotype of
these spores was inferred assuming 2:2 segregation of the auxotrophic
markers in the cross. No attempt was made to determine the morphology
of spores/colonies that were scored as inviable spores. Strains used in
these crosses were: A, BOY527 (ste4::LEU2) × BOY796
(cla4::TRP1); B, BOY1113 (akr1::URA3) × BOY796
(cla4::TRP1); C, BOY489 (ste20::TRP1) × BOY1162
(akr1::URA3); D, BOY1138 (bem1::LEU2) × BOY796
(cla4::TRP1). For the sterile mutations ste4 and ste20,
deletions were covered by plasmids containing the wild type genes to
allow mating. These plasmids were lost before sporulation of the
diploids.
|
|
CLN1/2 Are Required for Pseudohyphal and Haploid Invasive
Growth--
Besides roles in mating factor signal transduction and the
budding/cytokinesis cycle, Ste20 is essential for agar invasive growth
in haploid cells (7) and pseudohyphal growth in diploids (5).
Activation of these signal transduction pathways leads, among other
phenotypes, to a more polarized cell morphology. Since CLN1/2 has been implicated in polarized growth during the
vegetative cell cycle (50), and since the several lines of
experimentation shown above suggest a connection between Ste20 and
these G1 cyclins, we tested whether pseudohyphal and
haploid invasive growth depend on CLN1/2. For these assays
we used strains of the 1278b background (6) since strains from our
usual laboratory background (BF264-15D) did not display pseudohyphal or
haploid invasive growth (data not shown). On plates with low ammonium
sulfate concentration, wild type 1278b diploid cells display
filament formation which is clearly visible at the fringe of colonies
(Ref. 5 and Fig. 6A). In
contrast, diploid cells without CLN1 and CLN2
were strongly defective in the formation of these filaments (Fig.
6A). As a result of invasion of the agar in rich medium,
haploid 1278b wild type cells (7) and cells deleted for either
CLN1 or CLN2 remain attached to the agar plates
upon rinsing with water (Fig. 6B). However, isogenic cells
deleted for both CLN1 and CLN2 were strongly
defective in haploid invasive growth (Fig. 6B). These data
show that CLN1 and CLN2 are required for both
pseudohyphal and haploid invasive growth.

View larger version (112K):
[in this window]
[in a new window]
|
Fig. 6.
Pseudohyphal and haploid invasive growth
require CLN1/2. A, diploid MATa/MAT with
wild type CLN genotype (L5976, left) or
MATa/MAT cln1/cln1 cln2/cln2 CLN3/CLN3
(BOY1565, right) were grown on synthetic plates
with a low ammonium concentration and with glucose as a carbon source.
Photographs of colonies were taken after 5 days of incubation at
30 °C. B, haploid strains were patched onto YEPD plates,
incubated for 3 days at 30 °C, and then an additional 2 days at room
temperature. Pictures were taken before and after gentle rinsing of the
surface with water. Strains used were wild type (10560-4D),
cln1 (BOY1452), cln2 (BOY1459), cln1
cln2 (BOY1451).
|
|
 |
DISCUSSION |
Ste20 as the Site of Repression of Mating Factor Signal
Transduction by Cln1/2-Cdc28 Kinase--
Based on epistatic analysis
by several laboratories, the most likely linear sequence of activation
of mating factor pathway components is Ste2 Gpa1 Ste4/Ste18 Ste20 Ste5 Ste11 Ste7 Fus3/Kss1 Ste12 (1). It was
previously shown that repression of mating factor signal transduction
by Cln1/2-Cdc28 kinase takes place at a level in the pathway downstream
of Ste2 and Gpa1 (14). The effect of high level CLN2
expression in strains in which the pathway is activated at the level of
Ste4, Ste5, Ste20, Ste11, or Ste12 (Fig. 1) is most readily explained
by assuming that repression acts at a level at or downstream of Ste4
and at or upstream of Ste5, i.e. around the site of action
of Ste20. There is some indication, however, that the mating factor
signaling pathway may not be a linear pathway, especially in the region around Ste20 (36). This makes interpretation of the epistatic data
presented in Fig. 1 somewhat difficult. It is clear that the effect is
upstream of the Ste11-Ste7-MAP kinase cassette, based on observations
that high level CLN2 expression prevents mating
factor-induced hyperphosphorylation of Ste7 and activation of Fus3
(data not shown and Ref. 17), and, most importantly, on the observation
that high level CLN2 expression does not reduce SST2 transcription induced by hyperactive alleles of Ste11
(Figs. 1 and 2). On this latter point our experimental results differ from those obtained by Wassmann and Ammerer (17), although the conclusion that repression takes place upstream of Ste11 is not necessarily inconsistent with the data from Wassmann and Ammerer (see
Ref. 17). We do not know the reason for the difference in some
experimental results, but strain differences are unlikely, since in our
hands the same strains used by Wassmann and Ammerer show no signs of
signaling repression (data not shown). If repression acted at the level
of Ste11, as has been suggested (17), high level CLN2
expression would be expected to repress any signal resulting from
activation of the signal transduction pathway upstream of Ste11.
However, even though FUS1 induction by high level expression of an active allele of Ste20 requires Ste11 (confirming that Ste20 acts
upstream of Ste11), high level CLN2 expression cannot
repress the signal generated at the level of Ste20. This observation
suggests that repression of the mating factor signal transduction
pathway takes place at a level upstream of Ste11. Most of the epistatic experiments involved high level expression of signaling components in
combination with high levels of Cln2. In the interpretation of these
experiments, it should be kept in mind that the precise stoichiometry
between cyclin-CDK and mating factor signaling component could be an
important factor in the transcriptional induction of the mating factor
pathway. However, stoichiometric effects are unlikely to affect the
overall conclusions from our epistatic analysis, since experiments with
high and low level expression of activated alleles of Ste11 gave
essentially the same epistatic results. It is therefore reasonable to
suppose that the negative effect of Cln1/2-Cdc28 on the mating factor
signal transduction pathway takes place upstream of Ste11.
Independent from the epistatic analysis, our study of the mobility of
Ste20 on SDS-PAGE gels provides evidence for a connection between
Cln1/2-Cdc28 and Ste20. We find that the mobility of Ste20 changes
during the cell cycle, most likely as a result of protein phosphorylation (data not shown).2 These changes in Ste20
mobility (i) occur at about the time in the cell cycle when
Cln1/2-Cdc28 kinase is active, (ii) do not occur in the absence of Cln1
and Cln2, and (iii) are constitutive in cells with high level
expression of CLN2. In all these aspects, there is a good
correlation between alterations in Ste20 mobility and the previously
observed characteristics of repression of the mating factor signal
transduction (14). From the epistatic data and the observations on
protein mobility, it is reasonable to suggest Ste20 as a target of
Cln1/2-Cdc28 kinase.
Mechanism of Repression--
It is interesting to note that even
though Ste20 is present at all cell cycle positions, localization of
the protein to a specific site is only observed at emergent buds (9,
10), which is by approximation the period when the slower migrating form of Ste20 is observed. Even though CLN1/2 is required
for observation of the slow-migrating form of Ste20, there is no
indication that Cln1/2-Cdc28 is required for localization of Ste20:
GFP-Ste20 is properly localized to buds even in the absence of
CLN1 and CLN2.2 Proper localization
of Ste20 has been shown to require interaction with the small G-protein
Cdc42 (9, 10). It does not appear that the Ste20-Cdc42 interaction is
affected by Cln1/2-Cdc28, first because Ste20 localization is not
affected in cln1 cln2 cells,2 and second because
we did not see effects of high level expression of CLN2 on
the association between Ste20 and Cdc42 in a two-hybrid analysis (Ref.
8 and data not shown). Also, since Ste20 proteins with defective Cdc42
interaction are proficient in mating factor signal transduction
activity (9, 10), elimination of the interaction between Cdc42 and
Ste20 could not by itself explain the signaling defect of cells with
high level expression of CLN2.
Both the fast and slow migrating forms of Ste20 are phosphoproteins
(Ref. 51 and data not shown).2 The slower migrating form is
most likely phosphorylated on additional residues but does not differ
in in vitro kinase activity from the fast migrating
form.2,3 There are numerous
TP and SP residues (potential Cdc28 phosphorylation sites) in Ste20
(23), some of which have been shown to be phosphorylated (51).3 Alteration of those residues that are specifically
phosphorylated as a result of Cln1/2-Cdc28 activity is likely to
improve the understanding of the precise role of these modifications in
mating factor signaling repression by Cln1/2-Cdc28. Whether Ste20 is a
direct in vivo substrate for the Cln1/2-Cdc28 kinase remains to be established. The fact that Ste20 can serve as an in
vitro substrate for Cln2-Cdc282 is consistent with
that possibility. Our data leave open the possibility that other
proteins that act at the level Ste20 in the signal transduction pathway
(and that possibly interact with Ste20) are the direct targets for the
Cln1/2-Cdc28 kinase. The results from the epistatic experiments with
high level expression of Ste5 could indicate the existence of an
effector of the Cln1/2-Cdc28 kinase besides Ste20. One candidate, Akr1
(29, 46), does not appear to be involved in repression of mating factor
signal transduction, as high level CLN2 expression
effectively down-regulates mating factor signal transduction in
akr1 cells.4
Can Cln1 and Cln2 Alter Ste20 Function?--
In addition to a role
in mating factor signal transduction, Ste20 can function in
pseudohyphal growth (5), agar invasive growth (7), and in the
budding/cytokinesis cycle (8). It was shown previously that cln1
cln2 cla4 cells are inviable, with a phenotype similar to that
ste20 cla4 cells (8). This suggests that Cln1/2-Cdc28 and
Ste20 function in a similar pathway to rescue the inviability of
cla4 cells. Based on the lethal phenotype of akr1
cla4 and bem1 cla4 cells, this pathway may also include
Akr1 and Bem1. Here we show that the two other pathways that are known to require Ste20 also require Cln1 and Cln2 (Fig. 6). Therefore, Cln1
and Cln2 appear to be required for all the vegetative morphogenic functions in which Ste20 has been implicated. In contrast, Cln1 and
Cln2 are not required for morphogenesis or the signal transduction functions of Ste20 in response to mating factor. In fact, those sexual
functions are inhibited by Cln1/2-Cdc28 (14). Therefore, the effect of
Cln1/2-Cdc28 on Ste20 may be to promote the vegetative morphogenic
functions, while inhibiting the sexual functions (Fig. 7, A and B). Thus
Cln1/2-Cdc28 may contribute to make a switch at Start from a mating
differentiation-competent state in G1-phase to a mating
differentiation-incompetent and budding and morphogenesis-competent state in post-Start cells. In haploid cells, various components like
Ste20, Ste11, Ste7, and Ste12 can be used for both mating factor signal
transduction and haploid invasive growth (7). This has raised the issue
of signaling specificity. How does the signal from different
environmental triggers travel through the same pathway to produce
different biological outputs? It has been proposed that part of the
mechanism for achieving signal transduction specificity may be to use
different MAP kinases (Fus3 for mating and Kss1 for haploid invasive
growth) for different outputs (44, 52). The regulation of Ste20
function by Cln1/2-Cdc28 might be another way to achieve signaling
specificity by precluding the simultaneous activation of different
morphogenic programs which require similar components for signal
transduction. In this view, cells would be responsive to mating factor
signals in G1-phase, and once Ste20 is modified by
Cln1/2-Cdc28 at Start, cells will be unresponsive to mating factor and
able to respond to other environmental signals. This mechanism of
ensuring signaling specificity at a level upstream of the MAP kinase
cassette would rely on evolutionary conserved classes of proteins like
p21-activated-kinases (PAKs) and cyclin-dependent kinases
(CDKs). The degree of conservation is quite good and extends beyond
simple sequence similarities, as various PAKs can complement functions
of Ste20 (2) and some CDKs can complement the yeast counterpart. It is
possible that regulation of PAKs by CDKs is conserved in evolution and
provides a general mechanism for achieving signaling specificity.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 7.
Cln1/2-Cdc28 may be involved in changing
Ste20 from a kinase active in mating factor signal transduction into a
kinase active in morphogenic functions. For further explanation
see text.
|
|
 |
ACKNOWLEDGEMENTS |
We thank G. Ammerer, A. Bender, B. Benton, R. Davis, B. Errede, G. Fink, G. Sprague, and V. MacKay for plasmids
and/or strains. Special thanks to C. Wu, M. Whiteway, E. Leberer, and
M. Peter for reagents and communication of results prior to
publication; B. Benton for useful discussions; and J. Liu for excellent
technical assistance.
 |
FOOTNOTES |
*
This work was supported by the Norman and Rosita Winston
Foundation and U. S. Public Health Service Grant GM49716.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address and to whom correspondence should be addressed:
CADUS Pharmaceutical Corp., 777 Old Saw Mill River Road, Tarrytown, NY
10591. Tel.: 914-467-6294; Fax: 914-467-6299; E-mail: bert.oehlen{at}cadus.com.
The abbreviations used are:
PAK, p21-activated
kinases; CDK, cyclin-dependent kinase; PAGE, polyacrylamide
gel electrophoresis; MAP, mitogen-activated protein.
2
C. L. Wu, E. Leberer, and M. Whiteway,
personal communication.
3
K. Huang et al., unpublished
observations.
4
L. Oehlen, unpublished observations.
 |
REFERENCES |
-
Sprague, G. F.,
and Thorner, J. W.
(1992)
in
The Molecular and Cellular Biology of the Yeast Saccharomyces (Jones, E. W., Pringle, J. R., and Broach, J. R., eds), pp. 657-744, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Sells, M. A.,
and Chernoff, J.
(1997)
Trends Cell Biol.
7,
162-167
-
Bardwell, L.,
Cook, J. G.,
Inouye, C. J.,
and Thorner, J.
(1994)
Dev. Biol.
166,
363-379[CrossRef][Medline]
[Order article via Infotrieve]
-
Leberer, E.,
Thomas, D. Y.,
and Whiteway, M.
(1997)
Curr. Opin. Genet. & Dev.
7,
59-66[CrossRef][Medline]
[Order article via Infotrieve]
-
Gimeno, C. J.,
Ljungdahl, P. O.,
Styles, C. A.,
and Fink, G. R.
(1992)
Cell
68,
1077-1090[CrossRef][Medline]
[Order article via Infotrieve]
-
Liu, H.,
Styles, C. A.,
and Fink, G. R.
(1993)
Science
262,
1741-1744[Abstract/Free Full Text]
-
Roberts, R. L.,
and Fink, G. R.
(1994)
Genes Dev.
8,
2974-2985[Abstract/Free Full Text]
-
Cvrckova, F.,
De Virgilio, C.,
Manser, E.,
Pringle, J. R.,
and Nasmyth, K.
(1995)
Genes Dev.
9,
1817-1830[Abstract/Free Full Text]
-
Peter, M.,
Neiman, A. M.,
Park, H. O.,
Van Lohuizen, M.,
and Herskowitz, I.
(1996)
EMBO J.
15,
7046-7059[Medline]
[Order article via Infotrieve]
-
Leberer, E.,
Wu, C. L.,
Leeuw, T.,
Fourest-Lieuvin, A.,
Segall, J. E.,
and Thomas, D. Y.
(1997)
EMBO J.
16,
83-97[CrossRef][Medline]
[Order article via Infotrieve]
-
Oehlen, L. J. W. M.,
and Cross, F. R.
(1998)
J. Biol. Chem.
273,
8556-8559[Abstract/Free Full Text]
-
Benton, B. K.,
Tinkelenberg, A.,
Gonzalez, I.,
and Cross, F. R.
(1997)
Mol. Cell. Biol.
17,
5067-5076[Abstract]
-
Zanolari, B.,
and Riezman, H.
(1991)
Mol. Cell. Biol.
11,
5251-5258[Abstract/Free Full Text]
-
Oehlen, L. J. W. M.,
and Cross, F. R.
(1994)
Genes Dev.
8,
1058-1070[Abstract/Free Full Text]
-
Oehlen, L. J. W. M.,
McKinney, J. D.,
and Cross, F. R.
(1996)
Mol. Cell. Biol.
16,
2830-2837[Abstract]
-
McKinney, J. D.,
Chang, F.,
Heintz, N.,
and Cross, F. R.
(1993)
Genes Dev.
7,
833-843[Abstract/Free Full Text]
-
Wassmann, K.,
and Ammerer, G.
(1997)
J. Biol. Chem.
272,
13180-13188[Abstract/Free Full Text]
-
Cross, F. R.
(1995)
Curr. Opin. Cell Biol.
7,
790-797[CrossRef][Medline]
[Order article via Infotrieve]
-
Nasmyth, K.
(1996)
Trends Genet.
12,
405-412[CrossRef][Medline]
[Order article via Infotrieve]
-
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1987)
Current Protocols in Molecular Biology, Wiley Interscience, New York
-
Konopka, J. B.,
Jenness, D. D.,
and Hartwell, L. H.
(1988)
Cell
54,
609-620[CrossRef][Medline]
[Order article via Infotrieve]
-
Whiteway, M.,
Hougan, L.,
Dignard, D.,
Thomas, D. Y.,
Bell, L.,
Saari, G. C.,
Grant, F. J.,
O'Hara, P.,
and MacKay, V. L.
(1989)
Cell
56,
467-477[CrossRef][Medline]
[Order article via Infotrieve]
-
Leberer, E.,
Dignard, D.,
Hougan, L.,
Thomas, D. Y.,
and Whiteway, M.
(1992)
EMBO J.
11,
4805-4813[Medline]
[Order article via Infotrieve]
-
Stevenson, B. J.,
Rhodes, N.,
Errede, B.,
and Sprague, G. F., Jr.
(1992)
Genes Dev.
6,
1293-1304[Abstract/Free Full Text]
-
Company, M.,
and Errede, B.
(1988)
Mol. Cell. Biol.
8,
5299-5309[Abstract/Free Full Text]
-
Courchesne, W. E.,
Kunisawa, R.,
and Thorner, J.
(1989)
Cell
58,
1107-1119[CrossRef][Medline]
[Order article via Infotrieve]
-
Elion, E. A.,
Grisafi, P. L.,
and Fink, G. R.
(1990)
Cell
60,
649-664[CrossRef][Medline]
[Order article via Infotrieve]
-
Fields, S.,
and Herskowitz, I.
(1987)
Mol. Cell. Biol.
7,
3818-3821[Abstract/Free Full Text]
-
Kao, L. R.,
Peterson, J.,
Ji, R.,
Bender, L.,
and Bender, A.
(1996)
Mol. Cell. Biol.
16,
168-178[Abstract]
-
Chenevert, J.,
Corrado, K.,
Bender, A.,
Pringle, J.,
and Herskowitz, I.
(1992)
Nature
356,
77-79[CrossRef][Medline]
[Order article via Infotrieve]
-
Cross, F. R.
(1997)
Yeast
13,
647-653[CrossRef][Medline]
[Order article via Infotrieve]
-
Whiteway, M.,
Hougan, L.,
and Thomas, D. Y.
(1990)
Mol. Cell. Biol.
10,
217-222[Abstract/Free Full Text]
-
Ramer, S. W.,
and Davis, R. W.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
452-456[Abstract/Free Full Text]
-
Cairns, B. R.,
Ramer, S. W.,
and Kornberg, R. D.
(1992)
Genes Dev.
6,
1305-1318[Abstract/Free Full Text]
-
Dolan, J. W.,
and Fields, S.
(1990)
Genes Dev.
4,
492-502[Abstract/Free Full Text]
-
Akada, R.,
Kallal, L.,
Johnson, D. I.,
and Kurjan, J.
(1996)
Genetics
143,
103-117[Abstract]
-
Hasson, M. S.,
Blinder, D.,
Thorner, J.,
and Jenness, D. D.
(1994)
Mol. Cell. Biol.
14,
1054-1065[Abstract/Free Full Text]
-
Dietzel, C.,
and Kurjan, J.
(1987)
Mol. Cell. Biol.
7,
4169-4177[Abstract/Free Full Text]
-
Elion, E. A.
(1995)
Trends Cell Biol.
5,
322-327[CrossRef][Medline]
[Order article via Infotrieve]
-
Leberer, E.,
Dignard, D.,
Harcus, D.,
Hougan, L.,
Whiteway, M.,
and Thomas, D. Y.
(1993)
Mol. Gen. Genet.
241,
241-254[Medline]
[Order article via Infotrieve]
-
Zhou, Z.,
Gartner, A.,
Cade, R.,
Ammerer, G.,
and Errede, B.
(1993)
Mol. Cell. Biol.
13,
2069-2080[Abstract/Free Full Text]
-
Errede, B.,
Gartner, A.,
Zhou, Z.,
Nasmyth, K.,
and Ammerer, G.
(1993)
Nature
362,
261-264[CrossRef][Medline]
[Order article via Infotrieve]
-
Levine, K.,
Huang, K.,
and Cross, F. R.
(1996)
Mol. Cell. Biol.
16,
6794-6803[Abstract]
-
Cook, J. G.,
Bardwell, L.,
and Thorner, J.
(1997)
Nature
390,
85-88[CrossRef][Medline]
[Order article via Infotrieve]
-
Leeuw, T.,
Wu, C. L.,
Schrag, J. D.,
Whiteway, M.,
Thomas, D. Y.,
and Leberer, E.
(1998)
Nature
391,
191-195[CrossRef][Medline]
[Order article via Infotrieve]
-
Pryciak, P. M.,
and Hartwell, L. H.
(1996)
Mol. Cell. Biol.
16,
2614-2626[Abstract]
-
Leeuw, T.,
Fourest-Lieuvin, A.,
Wu, C. L.,
Chenevert, J.,
Clark, K.,
Whiteway, W.,
Thomas, D. Y.,
and Leberer, E.
(1995)
Science
270,
1210-1213[Abstract/Free Full Text]
-
Lyons, D. M.,
Mahanty, S. K.,
Choi, K. Y.,
Manandhar, M.,
and Elion, E. A.
(1996)
Mol. Cell. Biol.
16,
4095-4106[Abstract]
-
Leberer, E.,
Chenevert, J.,
Leeuw, T.,
Harcus, D.,
Herskowitz, I.,
and Thomas, D. Y.
(1996)
Mol. Gen. Genet.
252,
608-621[Medline]
[Order article via Infotrieve]
-
Lew, D. J.,
and Reed, S. I.
(1993)
J. Cell Biol.
120,
1305-1320[Abstract/Free Full Text]
-
Wu, C.,
Whiteway, M.,
Thomas, D. Y.,
and Leberer, E.
(1995)
J. Biol. Chem.
270,
15984-15992[Abstract/Free Full Text]
-
Madhani, H. D.,
Styles, C. A.,
and Fink, G. R.
(1997)
Cell
91,
673-684[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. A. Ydenberg and M. D. Rose
Antagonistic regulation of Fus2p nuclear localization by pheromone signaling and the cell cycle
J. Cell Biol.,
February 9, 2009;
184(3):
409 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Garrenton, A. Braunwarth, S. Irniger, E. Hurt, M. Kunzler, and J. Thorner
Nucleus-Specific and Cell Cycle-Regulated Degradation of Mitogen-Activated Protein Kinase Scaffold Protein Ste5 Contributes to the Control of Signaling Competence
Mol. Cell. Biol.,
January 15, 2009;
29(2):
582 - 601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-M. Zhao, R.-S. Wang, L. Chen, and K. Aihara
Uncovering signal transduction networks from high-throughput data by integer linear programming
Nucleic Acids Res.,
May 1, 2008;
36(9):
e48 - e48.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yu, M. Qi, M. A. Sheff, and E. A. Elion
Counteractive Control of Polarized Morphogenesis during Mating by Mitogen-activated Protein Kinase Fus3 and G1 Cyclin-dependent Kinase
Mol. Biol. Cell,
April 1, 2008;
19(4):
1739 - 1752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kjaerulff, N. R. Andersen, M. T. Borup, and O. Nielsen
Cdk phosphorylation of the Ste11 transcription factor constrains differentiation-specific transcription to G1
Genes & Dev.,
February 1, 2007;
21(3):
347 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang and H. G. Dohlman
Pheromone-regulated Sumoylation of Transcription Factors That Mediate the Invasive to Mating Developmental Switch in Yeast
J. Biol. Chem.,
January 27, 2006;
281(4):
1964 - 1969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hofmann, M. Shepelev, and J. Chernoff
The genetics of Pak
J. Cell Sci.,
September 1, 2004;
117(19):
4343 - 4354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Queralt and J. C. Igual
Functional Distinction Between Cln1p and Cln2p Cyclins in the Control of the Saccharomyces cerevisiae Mitotic Cycle
Genetics,
September 1, 2004;
168(1):
129 - 140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Palecek, A. S. Parikh, and S. J. Kron
Sensing, signalling and integrating physical processes during Saccharomyces cerevisiae invasive and filamentous growth
Microbiology,
April 1, 2002;
148(4):
893 - 907.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Edgington and B. Futcher
Relationship between the function and the location of G1 cyclins in S. cerevisiae
J. Cell Sci.,
March 14, 2002;
114(24):
4599 - 4611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-H. Ahn, B. T. Tobe, J. N. F. Gerald, S. L. Anderson, A. Acurio, and S. J. Kron
Enhanced Cell Polarity in Mutants of the Budding Yeast Cyclin-dependent Kinase Cdc28p
Mol. Biol. Cell,
November 1, 2001;
12(11):
3589 - 3600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. La Valle and C. Wittenberg
A Role for the Swe1 Checkpoint Kinase During Filamentous Growth of Saccharomyces cerevisiae
Genetics,
June 1, 2001;
158(2):
549 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Lengeler, R. C. Davidson, C. D'souza, T. Harashima, W.-C. Shen, P. Wang, X. Pan, M. Waugh, and J. Heitman
Signal Transduction Cascades Regulating Fungal Development and Virulence
Microbiol. Mol. Biol. Rev.,
December 1, 2000;
64(4):
746 - 785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-J. Sheu, Y. Barral, and M. Snyder
Polarized Growth Controls Cell Shape and Bipolar Bud Site Selection in Saccharomyces cerevisiae
Mol. Cell. Biol.,
July 15, 2000;
20(14):
5235 - 5247.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D Pruyne and A Bretscher
Polarization of cell growth in yeast. I. Establishment and maintenance of polarity states
J. Cell Sci.,
January 2, 2000;
113(3):
365 - 375.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. J. Loeb, T. A. Kerentseva, T. Pan, M. Sepulveda-Becerra, and H. Liu
Saccharomyces cerevisiae G1 Cyclins Are Differentially Involved in Invasive and Pseudohyphal Growth Independent of the Filamentation Mitogen-Activated Protein Kinase Pathway
Genetics,
December 1, 1999;
153(4):
1535 - 1546.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. D. Madhani, T. Galitski, E. S. Lander, and G. R. Fink
Effectors of a developmental mitogen-activated protein kinase cascade revealed by expression signatures of signaling mutants
PNAS,
October 26, 1999;
96(22):
12530 - 12535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-H. Ahn, A. Acurio, and S. J. Kron
Regulation of G2/M Progression by the STE Mitogen-activated Protein Kinase Pathway in Budding Yeast Filamentous Growth
Mol. Biol. Cell,
October 1, 1999;
10(10):
3301 - 3316.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Oda, K. Huang, F. R. Cross, D. Cowburn, and B. T. Chait
Accurate quantitation of protein expression and site-specific phosphorylation
PNAS,
June 8, 1999;
96(12):
6591 - 6596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. I. Johnson
Cdc42: An Essential Rho-Type GTPase Controlling Eukaryotic Cell Polarity
Microbiol. Mol. Biol. Rev.,
March 1, 1999;
63(1):
54 - 105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Edgington, M. J. Blacketer, T. A. Bierwagen, and A. M. Myers
Control of Saccharomyces cerevisiae Filamentous Growth by Cyclin-Dependent Kinase Cdc28
Mol. Cell. Biol.,
February 1, 1999;
19(2):
1369 - 1380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Bose, J. E. Irazoqui, J. J. Moskow, E. S. G. Bardes, T. R. Zyla, and D. J. Lew
Assembly of Scaffold-mediated Complexes Containing Cdc42p, the Exchange Factor Cdc24p, and the Effector Cla4p Required for Cell Cycle-regulated Phosphorylation of Cdc24p
J. Biol. Chem.,
March 2, 2001;
276(10):
7176 - 7186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Rashid, M. Banerjee, and M. Nikolic
Phosphorylation of Pak1 by the p35/Cdk5 Kinase Affects Neuronal Morphology
J. Biol. Chem.,
December 21, 2001;
276(52):
49043 - 49052.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|